Neophyllin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Neophyllin

Property Description
Active ingredient Aminophylline (Theophylline Ethylenediamine)
Forms Solution for injection, tablets, rectal suppositories
Pharmacological class Methylxanthine Derivative (Systemic Bronchodilator)
General purpose Relieving breathing difficulty caused by airway constriction
Origin Synthetic compound

Neophyllin is a systemic medication primarily recognized as a powerful bronchodilator used to manage conditions characterized by constricted airways. Its core identity is rooted in its active substance, Aminophylline, which is classified within the Methylxanthine derivative pharmacological group. This designation confirms it is clinically recognized for its therapeutic effects on the respiratory system. The medication is a synthetic compound designed to act throughout the body, providing relief from the physical narrowing of air passages.


1. Neophyllin: Identity and Pharmacological Classification

Neophyllin is defined by its active ingredient, Aminophylline (Theophylline Ethylenediamine), and is universally categorized as a systemic Methylxanthine derivative. The compound is structurally related to naturally occurring xanthine bases, but Aminophylline itself is chemically synthesized to ensure optimal stability and reliable systemic delivery. Its fundamental function is that of a bronchodilator, meaning its principal action is the relaxation and widening of the air passages within the lungs, facilitating respiration.


2. Composition, Forms, and General Therapeutic Purpose

The active ingredient, Aminophylline, is chemically defined as a salt formed by combining the therapeutic drug Theophylline with Ethylenediamine in a 2:1 ratio. This specific structure is crucial because the addition of Ethylenediamine significantly enhances the solubility of Theophylline, a differentiating factor that makes it highly effective for preparations requiring quick absorption, such as the solution for injection. Within the Methylxanthines class, these agents serve to reverse airway constriction, thereby supporting improved respiratory function. These pharmaceutical preparations include a sterile solution for injection (for rapid effect), tablets for oral administration, and rectal suppositories. The general purpose of this medication is to effectively counteract the narrowing of the airways by inducing bronchodilation, providing generalized relief from breathing difficulty.

What side effects are possible with Neophyllin?

Possible Side Effects and Safety Information

The adverse reactions associated with Neophyllin (Aminophylline) are primarily linked to its systemic stimulatory effects, which increase significantly if the concentration of the medicine in the blood exceeds the therapeutic range (>20 mu g/mL). The majority of effects are considered concentration-dependent and become more frequent and severe with higher exposure.


Official Safety Groupings

Adverse reactions are officially documented across several System-Organ Classes:

  • Nervous System Disorders: Common effects include headache, insomnia, nervousness, and tremor.
  • Cardiac Disorders: Recognized effects include palpitations, tachycardia (increased heart rate), and cardiac arrhythmias.
  • Gastrointestinal Disorders: Common side effects include nausea, vomiting, and abdominal pain.

Serious Adverse Reactions and Safety Constraints

The regulatory profile identifies certain serious risks. Potentially life-threatening events, such as seizures and severe cardiac arrhythmias (including cardiac arrest), are officially documented, primarily when serum levels are toxic.

Safety restrictions are outlined for specific patient groups. Older adults, individuals with hepatic impairment, or those with cardiac failure may have reduced clearance of the medicine, which increases the potential for adverse effects and necessitates caution. Furthermore, the label notes that administration with other xanthine derivatives is contraindicated due to the significantly increased risk of synergistic toxicity.

Overdose and Emergency Response

Overdose and When to Seek Help

Neophyllin is a medication derived from Theophylline, and its overdose profile centers on severe neurological and cardiac toxicity. An overdose occurs when a person takes more than the recommended amount, leading to toxic levels (typically serum levels ge 20 mcg/mL). Severe consequences, including death, are more common in the very young or the elderly.


Documented Overdose Presentations

The most life-threatening symptoms of an overdose are seizures (convulsions) and disturbances in heart rhythm (cardiac arrhythmias). Other serious manifestations include signs of shock, severe low or high blood pressure, and gastrointestinal hemorrhage. Less severe but indicative symptoms often include persistent nausea, vomiting, diarrhea, abdominal pain, agitation, severe headache, and uncontrolled tremors.


Required Emergency Action

IMMEDIATE MEDICAL HELP IS REQUIRED if an overdose is suspected or has occurred. This includes calling an emergency number (such as 911 or local equivalent) or a poison control center right away.

Stop taking Neophyllin and see a doctor immediately if any severe symptoms develop, such as difficulty breathing, loss of consciousness, signs of liver dysfunction (jaundice), or severe muscle pain/weakness (signs of rhabdomyolysis). Do not attempt to induce vomiting unless specifically advised to do so by a healthcare provider or poison control.

Therapeutic Uses of Neophyllin

Quick Facts: Neophyllin Therapeutic Domains

  • May assist in managing symptoms associated with: Chronic Obstructive Pulmonary Disease (COPD).
  • Is used to address issues related to: Asthma and other reversible airflow obstructions.
  • May offer support for: Breathing difficulties associated with airway obstruction.

Neophyllin is an approved treatment used to address symptoms associated with obstructive pulmonary diseases and asthma.

The use of this compound may help patients manage airway obstruction and the resulting difficulties with breathing. For individuals with asthma, this medication is typically utilized as an add-on therapy when symptoms are not adequately managed by other initial treatments. It is also used as part of the management plan for patients with Chronic Obstructive Pulmonary Disease (COPD), especially for those experiencing severe disease not fully controlled by other standard bronchodilator therapies.

This medication has demonstrated effectiveness in addressing various respiratory conditions that obstruct the airways. Clinical applications of the compound may also support improved exercise tolerance in certain patient populations.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Neophyllin (Aminophylline)

The population eligibility for Neophyllin is strictly defined by regulatory documents, distinguishing between approved use, mandatory caution, and absolute prohibition.


Contraindications (Must Not Use)

Official labels strictly contraindicate the use of Neophyllin for patients with:

  • Known hypersensitivity or allergy to aminophylline, theophylline, ethylenediamine, or any components of the formulation.
  • A diagnosis of acute porphyria (as specified in certain regulatory documents).

Age- and Condition-Based Restrictions

Use is generally approved for adults and children over 6 months.

Population Group Regulatory Stance
Infants (<6 months) Not recommended due to highly variable and unpredictable drug clearance.
Older Adults (>60 years) Use with caution and monitoring due to age-related decrease in clearance.
Hepatic or Cardiac Impairment Use with extreme caution; clearance is often significantly reduced (e.g., in liver disease or Congestive Heart Failure).
Pregnancy/Lactation Use only if clearly essential during pregnancy; generally not recommended during breastfeeding as the drug passes into milk.

Extreme caution is also mandated for patients with concurrent conditions such as active peptic ulcer disease, seizure disorders, or certain cardiac arrhythmias, due to the risk of exacerbation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Neophyllin (Aminophylline/Theophylline) is formally documented in regulatory sources and is largely governed by alterations in hepatic clearance.

Contraindicated and Restricted Combinations

Contraindicated combinations include the co-administration of other Xanthine Derivatives (such as Theophylline) due to the severe hazard of toxicity from excessive plasma concentrations. Co-use with Riociguat and Viloxazine is also restricted in regulatory warnings.

Exposure-Altering Drug Interactions

Interactions involving the alteration of hepatic clearance via the CYP enzyme system are frequently cited. Several medicines can increase Neophyllin's plasma levels, including the antidepressant Fluvoxamine, the antibiotics Ciprofloxacin and Erythromycin, and Cimetidine. Conversely, medicines such as the anti-seizure drugs Phenytoin and Carbamazepine, along with Rifampicin, may decrease Neophyllin concentrations, diminishing its effect.

Pharmacodynamic and Lifestyle Interactions

Pharmacodynamic interactions involve additive or antagonistic effects. Co-administration with Sympathomimetics increases the risk of synergistic cardiotoxicity, while Beta-blockers may antagonize the bronchodilator action. Regulatory information notes that smoking tobacco can decrease Neophyllin effectiveness, and high intake of caffeine may add to its central nervous system stimulant effects.

Population-Specific Notes

Clearance is officially noted to be decreased in elderly patients and those with hepatic dysfunction, which increases the potential for greater systemic exposure and interaction significance.

Mechanism of Action

The Pharmacodynamic Mechanism of Neophyllin

Neophyllin's mechanism of action is mediated by its active component, Theophylline, which acts on two distinct domains. The primary action is as a non-selective inhibitor of Phosphodiesterase ( PDE) enzymes, particularly PDE3 and PDE4 isoforms, within airway smooth muscle cells. This enzyme blockade prevents the breakdown of cyclic adenosine monophosphate ( cAMP), sustaining elevated cAMP levels. The resulting intracellular cascade inactivates the necessary machinery for muscle contraction, yielding the physical relaxation of bronchial smooth muscle.

Secondly, Theophylline acts as a non-selective antagonist of adenosine receptors ( A1, A2A, A2B), modulating signaling that contributes to heightened airway reactivity and reducing the release of pro-inflammatory mediators. Furthermore, the drug is involved in the suppression of inflammatory gene transcription by modulating Histone Deacetylase-2 ( HDAC2) activity. These two complementary mechanisms operate simultaneously on both smooth muscle tone regulation and inflammatory signaling pathways.

Dosage and Administration Information

How to Use Neophyllin

Neophyllin (Aminophylline) administration follows established parameters which detail the appropriate routes, dosing, and procedural constraints for its use. The medication is used through a dual-route administration pattern, employing Intravenous (IV) injection or infusion for the immediate, acute management of severe breathing difficulties, and Oral (tablets) or Rectal (suppositories) routes for non-acute, long-term maintenance therapy.


Administration and Dosage Parameters

Parameter Instruction
Administration Route IV (Acute); Oral, Rectal (Maintenance)
IV Loading Dose 5.7 mg/kg (ideal body weight) over 20–30 minutes (no prior theophylline)
IV Maintenance Rate Usually 0.5 mg/kg/hour constant infusion for non-smokers
Oral Schedule Typically divided doses taken every 6 to 8 hours
Intake Conditions Oral forms should be taken with water on an empty stomach; extended-release tablets must be swallowed whole and not crushed
IV Procedural Rule The infusion rate must not exceed 25 mg per minute

Use Protocol

Dosage is not fixed and requires individual titration guided by Therapeutic Drug Monitoring (TDM) to maintain the target serum theophylline concentration (typically 10 to 15 mcg/mL). For populations with reduced drug clearance, such as older adults or those with hepatic or cardiac impairment, a substantially lower maintenance dose or infusion rate is required. A loading dose should not be given if the patient has received any theophylline product within the preceding 24 hours without prior serum level verification.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Neophyllin

This summary describes the types of research and the study populations that have been monitored, focusing on the available evidence for Neophyllin (Aminophylline) without making claims about effectiveness or providing medical advice.


Evidence for Use in Chronic Obstructive Pulmonary Disease (COPD)

Research was evaluated in adults with COPD, a condition marked by functional limitations in breathing. The evidence comes primarily from Randomized Controlled Trials (RCTs) and systematic reviews in conditions presenting with cycles of stability and flare-ups, including studies conducted during periods of increased symptom activity (acute exacerbations). Studies monitored objective measures of lung function (FEV1, FVC) and changes in blood gas levelsoutcomes related to systemic or functional imbalance. Data show patterns related to specific physiological measurements in observed populations, but the magnitude of these observations has often been characterized as modest in published trials. Furthermore, research highlights that the consistency of these observed changes is less certain for patient-reported experiences, such as sustained symptom severity.


Evidence for Use in Asthma

Neophyllin was studied for its role as an add-on therapy for chronic asthma and was evaluated in patients experiencing conditions associated with acute or disruptive episodes. Studies monitored objective measures of breathing capacity, such as peak expiratory flow (PEF), and tracked outcomes describing episodic or acute changes, including hospital admission rates. Research provides insight into short-term changes in lung function. However, when used as an addition to standard modern therapies, findings were mixed, and studies reported patterns where adding the compound was not consistently associated with additional observed changes on measures like airflow outcomes or hospital admission rates.


What is Still Uncertain About Neophyllin Research

The research on Neophyllin highlights several areas where certainty remains low or where research is ongoing. Data for certain groups remain insufficient, especially for patients with co-existing health conditions (comorbidities) and for long-term effects in the older patient population. While studies monitored objective physiological measures, comparative evidence is lacking to fully establish a consistent pattern between these technical measures and patient-reported outcomes describing perceived discomfort.

Key Studies & References

  1. Aminophylline injection, solution - Full Prescribing Information (DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Neophyllin (FAQ)

Q: What is Neophyllin used for besides the main condition?

A: Official medication information indicates that Neophyllin (Aminophylline) is used to manage the symptoms of chronic obstructive lung diseases, such as asthma, chronic bronchitis, and emphysema. While these are the primary uses, the drug may be prescribed for other purposes not fully detailed in standard patient guides. The full list of a person’s intended uses is determined by their healthcare provider.

Q: Do I need a prescription to get Neophyllin?

A: Regulatory documents indicate that this medication requires a prescription from a healthcare provider. It is classified as a prescription-only medicine and is not available over-the-counter.

Q: How long does it typically take for Neophyllin to start working?

A: Regulatory information for immediate-release oral forms suggests that the active substance, theophylline, is absorbed quickly and usually reaches its highest level in the bloodstream within one to two hours. Official sources indicate that this medicine is not classified for the relief of sudden or acute breathing difficulties.

Q: Can Neophyllin be taken with a common pain reliever like acetaminophen?

A: Authoritative drug interaction reports advise caution when combining Neophyllin with many common over-the-counter medicines, including those that contain acetaminophen. These combinations may affect blood levels and necessitates awareness by the prescribing professional.

Q: Is it common to feel tired when starting Neophyllin?

A: While tiredness is not listed as a universally common side effect in core regulatory warnings, unusual tiredness or weakness is among the effects that have been reported with this class of medicine. Other neurological side effects, such as nervousness and trouble sleeping (insomnia), are common.

Q: Are there any foods or drinks to avoid while using Neophyllin?

A: Regulatory documents advise limiting the intake of caffeine, as its stimulant properties can add to the side effects of Neophyllin, such as nervousness and increased heart rate. The drug's clearance may also be affected by certain significant changes in diet, such as a high carbohydrate/low protein diet, and official guidance advises caution regarding concurrent use of alcohol.

Q: Can people with kidney problems take Neophyllin?

A: Regulatory information states that Neophyllin should be used with caution in individuals who have impaired kidney function (renal impairment). Kidney issues can lead to an accumulation of the medicine in the body, which may increase the risk of unwanted effects.

Q: What is the difference between Neophyllin and a steroid?

A: Neophyllin is officially classified as a Methylxanthine derivative, working primarily as a bronchodilator by relaxing the smooth muscles of the airways. Steroids belong to a different drug class (corticosteroids) that provide a general anti-inflammatory effect. While Neophyllin has some anti-inflammatory properties, its primary mechanism is noted to be distinct from that of corticosteroids.

Q: Does Neophyllin cause weight gain or weight loss?

A: Official safety documents have listed weight gain as a possible adverse reaction for the active ingredient, theophylline. However, weight changes are not consistently listed among the common or frequent side effects in the core regulatory warnings.

Q: Is there any research evidence on Neophyllin for long-term use?

A: Official research summaries have documented the use of theophylline in longer-duration studies, sometimes showing sustained physiological changes over periods lasting several months. However, authoritative research summaries note that the long-term effects in all patient populations remain an area where certainty is low.

Q: What are the most common reasons doctors prescribe Neophyllin?

A: According to official product information, Neophyllin (Aminophylline) is indicated for the management of symptoms associated with chronic obstructive lung conditions. These most commonly include asthma, chronic bronchitis, and emphysema.

Q: Does Neophyllin interact with vitamins or herbal supplements?

A: Official drug interaction reports advise caution because many products, including prescription and over-the-counter medicines, vitamins, and herbal supplements (such as St. John's wort), may interact with theophylline. These interactions can alter how the drug is processed in the body, potentially changing its effectiveness or increasing side effects.

Q: Is Neophyllin used for prevention or just for treatment?

A: The primary role of Neophyllin (Aminophylline) is described in official sources as treating the symptoms of chronic obstructive lung diseases. However, some clinical studies have also monitored its potential for a preventative effect in certain specific conditions, such as reducing episodes of apnea in premature infants.

Q: Are there different strengths of Neophyllin tablets?

A: Yes, official prescribing information confirms that oral tablets of Neophyllin (Aminophylline dihydrate) are available in different strengths for administration, such as 100 mg and 200 mg tablets.

Q: Is there a generic version of Neophyllin available?

A: Authoritative sources, including those in the US, confirm that a generic version of the active ingredient, Aminophylline, is available.

Q: What happens if Neophyllin is taken with alcohol?

A: Official documents reflect that the combination of this medicine with alcohol may increase the risk of experiencing certain side effects.

Q: Will taking Neophyllin impact my ability to drive or operate machinery?

A: Regulatory safety messaging and the listed central nervous system side effects (like dizziness, insomnia, and tremor) suggest that individuals should observe their reaction to the medication before engaging in activities that require full attention.

Q: Is Neophyllin known to interact with birth control pills?

A: Yes, official drug interaction reports note that contraceptive steroids (the active components in many birth control pills) may interact with Neophyllin. These steroids can slow down the body's breakdown of theophylline, which may increase the amount of theophylline in the blood. For this reason, caution is advised when they are taken together.

Q: Is it normal for Neophyllin to cause slight dizziness?

A: Dizziness is documented in authoritative side effect listings for theophylline, the active component of Neophyllin. While not always listed among the most common adverse events, this symptom has been reported in official documents.

Q: Is Neophyllin approved in other countries besides the US and Europe?

A: Review of regulatory data indicates that the drug is authorized for use by international bodies beyond the US and Europe. It is registered and approved by several other national drug regulatory agencies globally, indicating that its authorization extends to various international regions.

Q: What common over-the-counter cold medicines are mentioned as potential interactions with Neophyllin?

A: Regulatory resources and interaction reports note that caution is needed with many over-the-counter cold and pain products. This is particularly true for medicines containing ingredients like phenylephrine, a sympathomimetic often found in common decongestants. Combining these products may increase the risk of certain side effects.

How should Neophyllin be stored and disposed of?

Storage and Disposal of Neophyllin

Official labeling defines strict storage conditions for Neophyllin (Aminophylline).

Storage Requirements

Formulation Temperature Requirement Protection Mandate
Injection Store at 20 C to 25 C Protect from light and Do not freeze
Oral Forms Store below 30 C (or 25 C) Keep container tightly closed in original packaging

All forms must be stored out of the sight and reach of children.

Disposal

Unused portions of single-dose injectable solutions must be discarded. Expired or unused medicine must be disposed of in accordance with local requirements for pharmaceutical waste. Do not dispose of the medication via wastewater or household trash unless explicitly instructed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Neophyllin found in:

A-Z Index: